Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
I received the shot and I have been Sick starting the following day; weak running a fever; weak running a fever; night and waking up drenched. I am in the 4th day; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. The patient received Arexvy. The patient experienced sickness (Verbatim: I received the shot and I have been Sick starting the following day), weakness (Verbatim: weak running a fever), fever (Verbatim: weak running a fever) and drenching sweats (Verbatim: night and waking up drenched. I am in the 4th day). The outcome of the sickness, weakness, fever and drenching sweats were not resolved. It was unknown if the reporter considered the sickness, weakness, fever and drenching sweats to be related to Arexvy. It was unknown if the company considered the sickness, weakness, fever and drenching sweats to be related to Arexvy. Additional Information: GSK Receipt Date: 20-SEP-2025 The batch number was not provided, and we are unable to contact the reporter.